Willem-jan R. Fokkink

Dr. Molewaterplein 40
Rotterdam, ZH 3015GD, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Genetic variation of low-to-medium-affinity Fc-gamma receptors in Guillain-Barré syndrome.

Genetic variation of low-to-medium-affinity Fc-gamma receptors in Guillain-Barré syndrome.

Journal: Journal of neurology

Published: December 13, 2024

Novel approach to monitor intravenous immunoglobulin pharmacokinetics in humans using polymorphic determinants in IgG1 constant domains.

Novel approach to monitor intravenous immunoglobulin pharmacokinetics in humans using polymorphic determinants in IgG1 constant domains.

Journal: European journal of immunology

Published: September 24, 2021

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy.

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy.

Journal: European journal of neurology

Published: December 11, 2020

Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.

Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.

Journal: Journal of the peripheral nervous system : JPNS

Published: July 02, 2018

Protocol of a dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (DRIP study).

Protocol of a dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (DRIP study).

Journal: Journal of the peripheral nervous system : JPNS

Published: October 27, 2017

Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy.

Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy.

Journal: Journal of the peripheral nervous system : JPNS

Published: August 06, 2017

Could Albumin be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barré Syndrome?-Reply.

Could Albumin be a Biomarker to Monitor the Effect of Intravenous Immunoglobulin on Guillain-Barré Syndrome?-Reply.

Journal: JAMA neurology

Published: May 16, 2017

Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barré Syndrome.

Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barré Syndrome.

Journal: JAMA neurology

Published: December 28, 2016

Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS.

Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS.

Journal: Annals of clinical and translational neurology

Published: March 18, 2016

IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.

IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.

Journal: Journal of proteome research

Published: February 19, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026